Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
Researchers at the University of California at Davis combined ultrasound with light into a catheter probe to view the tiny arteries of the heart.
The device uses intravascular ultrasound and fluorescence lifetime imaging (FLIm) to retrieve structural and biochemical information about plaque in the arteries to help predict heart attacks more reliably, according to the researchers. Read more
OrthoPediatrics yesterday priced the range on its initial public offering, looking to float 4 million shares of common stock at between $12 and $14 per share, which would bring in between $48 and $56 million.
The offering also includes a 30-day underwriter’s option to purchase an additional 600,000 shares of common stock, bringing the possible total the company could raise in the offering up to $64.4 million.s Read more
Hemostatic device developer Z-Medica this week received a majority investment from private equity firm Linden Capital Partners as the company looks to continue expanding the availability of its QuickClot hemostatic products.
The investment places Linden Capital alongside current shareholders DW Healthcare Partners, who invested in the company in 2012, according to a statement from CEO Stephen Fanning. Read more
Abbott said today it closed its tender offer for all outstanding Alere Series B convertible perpetual preferred stock shares at $402 per share.
The offer was made in connection with Abbott’s acquisition of Alere, which closed yesterday. Read more
Hologic today announced both a private offering of $350 million in senior notes due 2025 and $3 billion from a new term loan and revolving credit facility as it looks to restructure its finances.
The Marlborough, Mass.-based company said it expects to use the funds from both the $350 million offering and new credit agreement to retire its remaining convertible notes after they become callable in December 2017 and March 2018, according to a press release. Read more